Hypertrichosis-Acromegaloid Facial Appearance SyndromeSymptoms, Doctors, Treatments, Advances & More
Hypertrichosis-Acromegaloid Facial Appearance Syndrome Overview
Learn About Hypertrichosis-Acromegaloid Facial Appearance Syndrome
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Cedars-Sinai Pituitary Center
Shlomo Melmed is an Endocrinologist practicing medicine in Los Angeles, California. Dr. Melmed is rated as an Elite provider by MediFind in the treatment of Hypertrichosis-Acromegaloid Facial Appearance Syndrome. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Acromegaly, Acromegaloid Facial Appearance Syndrome, Hypertrichosis-Acromegaloid Facial Appearance Syndrome, Pituitary Tumor, and Hormone Replacement Therapy (HRT).
CUIMC/Harkness Pavilion
Pamela Freda is an Oncologist practicing medicine in New York, New York. Dr. Freda is rated as an Elite provider by MediFind in the treatment of Hypertrichosis-Acromegaloid Facial Appearance Syndrome. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Acromegaly, Acromegaloid Facial Appearance Syndrome, Hypertrichosis-Acromegaloid Facial Appearance Syndrome, and Pituitary Tumor.
Massachusetts General Hospital Neuroendocrine & Pituitary Tumor Clinical Center
Lisa Nachtigall is an Endocrinologist practicing medicine in Boston, Massachusetts. Dr. Nachtigall is rated as an Elite provider by MediFind in the treatment of Hypertrichosis-Acromegaloid Facial Appearance Syndrome. She is also highly rated in 35 other conditions, according to our data. Her clinical expertise encompasses Acromegaly, Hypertrichosis-Acromegaloid Facial Appearance Syndrome, Acromegaloid Facial Appearance Syndrome, and Pituitary Tumor.
Summary: There is a variety of tumors affecting the pituitary gland in childhood; some of these tumors (eg craniopharyngioma) are included among the most common central nervous system tumors in childhood. The gene(s) involved in the pathogenesis of these tumors are largely not known; their possible association with other developmental defects or inheritance pattern(s) has not been investigated. The present...
Summary: The purpose of this study is to collect long-term (up to two years) safety and effectiveness of octreotide subcutaneous depot in patients with acromegaly in the real-world setting.